Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Obstetrics

Will Non-Immune Hydrops Fetalis Happen Again?

At a Glance

The recurrence risk for non-immune hydrops fetalis (NIHF) depends entirely on its underlying cause. Risks are very low if caused by a viral infection or spontaneous chromosomal error. If caused by an inherited genetic condition, the risk can be up to 50% in future pregnancies.

If your pregnancy was complicated by non-immune hydrops fetalis (NIHF), you have likely endured profound emotional pain and loss. As you navigate this grief, wondering whether this could happen again is a natural, albeit stressful, concern. The short answer is that the recurrence risk depends entirely on the underlying cause of the hydrops [1][2]. For some families, the risk of NIHF happening in a future pregnancy is close to zero, while for others, the risk can be 25% or 50% [1][3]. Because the risk varies so widely, discovering the exact reason for the hydrops is the most critical step in understanding your chances for a healthy future pregnancy [2].

When the Recurrence Risk is Low

In many cases, NIHF is caused by a one-time, isolated event that is highly unlikely to happen again.

  • Viral Infections: If the hydrops was caused by a maternal infection during pregnancy—most commonly Parvovirus B19 (Fifth disease) or Cytomegalovirus (CMV)—the risk of it recurring is extremely low [4][5]. Once you have been exposed to these specific viruses, your immune system typically builds antibodies that provide robust protection against them for future pregnancies [6]. However, practicing standard hygiene, like frequent handwashing around toddlers, remains important to protect against other distinct viral exposures.
  • Spontaneous Chromosomal Changes: Sometimes, NIHF is caused by random errors in cell division, leading to missing or extra chromosomes (aneuploidy), such as Turner syndrome or Down syndrome. If genetic testing shows that this was a de novo (new and spontaneous) event rather than something inherited from a parent, the chances of it happening again are generally very low [7][8]. Doctors often quote a tiny risk (around 1%) just in case the genetic change is hidden in a small portion of a parent’s reproductive cells (germline mosaicism) [1].

When the Recurrence Risk is Higher

If the hydrops was caused by a genetic disorder passed down from the parents, the chance of recurrence is significantly higher [2][1].

  • Autosomal Recessive Conditions (25% Risk): If both parents are healthy carriers of a specific genetic mutation, there is a 1 in 4 (25%) chance in every pregnancy that the baby will inherit the condition [1]. Common examples linked to NIHF include alpha-thalassemia (a severe blood disorder) and certain lysosomal storage diseases (metabolic disorders where the body cannot break down cellular waste) [1][9][10].
  • Autosomal Dominant Conditions (50% Risk of Passing the Gene): In these conditions, a mutation from just one parent can cause the disorder. If a parent has the condition (even mildly), there is a 50% chance of passing the gene on [1][11]. This inheritance pattern is sometimes seen in RASopathies, a group of genetic syndromes that affect how cells communicate and grow [1][12].
  • X-Linked Conditions: If a mother is a healthy carrier of a mutation on her X chromosome, there is a 50% chance in every pregnancy that a male baby will inherit the condition [1].
  • Parental Chromosomal Translocations: While spontaneous chromosomal issues rarely recur, if one parent carries a “balanced translocation” (where pieces of chromosomes are rearranged but the parent is healthy), the risk of passing on an unbalanced set of chromosomes to the baby is elevated [7][8].

What If the Cause Is Still Unknown?

Sometimes, standard prenatal testing (like ultrasound and basic chromosomal microarrays) cannot find the reason for the hydrops. Historically, these cases were labeled idiopathic (unexplained) [13].

When the cause is truly unknown, doctors cannot give an exact percentage for recurrence risk. However, recent medical advances have shown that about one-third of these “unexplained” cases actually have a hidden genetic cause [12][14]. Advanced genetic testing, such as Exome Sequencing (ES), can look much deeper into the DNA to find these rare mutations [2][1]. If a genetic cause is suspected but not found, doctors generally advise that some level of recurrence risk still exists [1][13].

Preparing for Future Pregnancies

Before trying to conceive again, it is strongly recommended that you seek preconception counseling with a maternal-fetal medicine specialist or a genetic counselor [1][3]. The anxiety of trying to conceive again after an NIHF pregnancy can be paralyzing, and working with both medical specialists and a mental health professional experienced in pregnancy loss can offer vital support. Your medical team can help you build a personalized family planning strategy by:

  • Reviewing Past Records: They will gently look at all previous ultrasounds, blood work, and results from any postnatal evaluations or tissue testing to search for missed clues.
  • Advanced Genetic Testing: If you haven’t already had it, they may recommend exome sequencing using stored tissue from your previous pregnancy alongside blood samples from both parents (called “trio testing”) [2][1]. If you were unable to get genetic testing done on the baby at the time, do not lose hope—doctors can often still test the parents to find important clues about potential risks.
  • Exploring Reproductive Options: If a genetic cause with a high recurrence risk is identified, you have options. Many families choose Preimplantation Genetic Testing (PGT-M), a process used during IVF to screen embryos for the specific genetic condition before pregnancy begins [15][16].
  • Planning Early Surveillance: Regardless of the cause, your doctor will likely recommend closer monitoring in your next pregnancy, including early, detailed ultrasounds and fetal echocardiograms to watch for any early signs of fluid buildup [3][17].

Common questions in this guide

Will non-immune hydrops fetalis happen again in my next pregnancy?
The chance of non-immune hydrops fetalis happening again depends on what caused it initially. If it was caused by a viral infection or a spontaneous chromosomal error, the risk is usually very low. If it was caused by an inherited genetic condition, the risk can be between 25% and 50%.
What if doctors never found the cause of the hydrops?
Advanced testing, like exome sequencing, reveals that about one-third of unexplained cases actually have a hidden genetic cause. If doctors still cannot find any underlying cause after comprehensive testing, they generally advise that some level of recurrence risk still exists.
How can we prevent hydrops fetalis in future pregnancies?
If a specific inherited genetic cause is found, families may choose Preimplantation Genetic Testing (PGT-M) during IVF to screen embryos before pregnancy. Regardless of the cause, doctors highly recommend preconception counseling and early, detailed ultrasounds in the next pregnancy.
Do both parents need genetic testing if we had a previous pregnancy with hydrops?
Yes, genetic testing for both parents is highly recommended. Even if tissue from the previous pregnancy is unavailable, doctors can often test the parents' blood to find important clues about potential inherited risks, such as autosomal recessive or X-linked genetic conditions.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on the records and testing from my previous pregnancy, which specific recurrence risk category do I fall into?
  2. 2.Are there any advanced genetic tests, like Exome Sequencing, that we should perform on myself, my partner, or stored tissue before trying to conceive again?
  3. 3.If we do not know the exact cause of the hydrops, what surveillance protocol or early ultrasounds do you recommend for my next pregnancy?
  4. 4.Should my partner and I undergo expanded carrier screening to rule out autosomal recessive or X-linked conditions?
  5. 5.If a high recurrence risk is identified, can you refer us to a reproductive endocrinologist to discuss Preimplantation Genetic Testing (PGT-M)?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (17)
  1. 1

    Value of Exome Sequencing in Diagnosis and Management of Recurrent Non-immune Hydrops Fetalis: A Retrospective Analysis.

    Zhou X, Zhou J, Wei X, et al.

    Frontiers in genetics 2021; (12()):616392 doi:10.3389/fgene.2021.616392.

    PMID: 33897756
  2. 2

    Diagnostic yield from prenatal exome sequencing for non-immune hydrops fetalis: A systematic review and meta-analysis.

    Al-Kouatly HB, Shivashankar K, Mossayebi MH, et al.

    Clinical genetics 2023; (103(5)):503-512 doi:10.1111/cge.14309.

    PMID: 36757664
  3. 3

    No. 363-Investigation and Management of Non-immune Fetal Hydrops.

    Désilets V, De Bie I, Audibert F

    Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 2018; (40(8)):1077-1090 doi:10.1016/j.jogc.2017.12.011.

    PMID: 30103882
  4. 4

    Percutaneous umbilical blood sampling: current trends and outcomes.

    Bigelow CA, Cinelli CM, Little SE, et al.

    European journal of obstetrics, gynecology, and reproductive biology 2016; (200()):98-101.

    PMID: 27014852
  5. 5

    Confirmation of etiology in fetal hydrops by sonographic evaluation of fluid allocation patterns.

    Hartge DR, Weichert J, Gembicki M, Krapp M

    European journal of obstetrics, gynecology, and reproductive biology 2015; (195()):128-132 doi:10.1016/j.ejogrb.2015.09.006.

    PMID: 26540593
  6. 6

    Parvovirus B19 infection during pregnancy and risks to the fetus.

    Ornoy A, Ergaz Z

    Birth defects research 2017; (109(5)):311-323 doi:10.1002/bdra.23588.

    PMID: 28398685
  7. 7

    Genetic disorders and pregnancy outcomes of non-immune hydrops fetalis in a tertiary referral center.

    Guo D, He S, Lin N, et al.

    BMC medical genomics 2023; (16(1)):83 doi:10.1186/s12920-023-01505-y.

    PMID: 37081464
  8. 8

    First trimester cystic hygroma colli: Retrospective analysis in a tertiary center.

    Schreurs L, Lannoo L, De Catte L, et al.

    European journal of obstetrics, gynecology, and reproductive biology 2018; (231()):60-64 doi:10.1016/j.ejogrb.2018.10.019.

    PMID: 30321790
  9. 9

    Lysosomal storage disorders in nonimmune hydrops fetalis diagnosed by exome sequencing.

    Makhamreh MM, Shivashankar K, Rice SM, et al.

    Orphanet journal of rare diseases 2025; (20(1)):351 doi:10.1186/s13023-025-03851-9.

    PMID: 40640912
  10. 10

    Iron overload in transfusion-dependent survivors of hemoglobin Bart's hydrops fetalis.

    Amid A, Chen S, Athale U, et al.

    Haematologica 2018; (103(5)):e184-e187 doi:10.3324/haematol.2017.178368.

    PMID: 29371322
  11. 11

    The many etiologies of nonimmune hydrops fetalis diagnosed by exome sequencing.

    Wagner T, Fahham D, Frumkin A, et al.

    Prenatal diagnosis 2022; (42(7)):881-889 doi:10.1002/pd.5977.

    PMID: 34132406
  12. 12

    Exome Sequencing for Prenatal Diagnosis in Nonimmune Hydrops Fetalis.

    Sparks TN, Lianoglou BR, Adami RR, et al.

    The New England journal of medicine 2020; (383(18)):1746-1756 doi:10.1056/NEJMoa2023643.

    PMID: 33027564
  13. 13

    A single center experience in 90 cases with nonimmune hydrops fetalis: diagnostic categories ‒ mostly aneuploidy and still often idiopathic.

    Sturm J, Milera H, Essmann S, et al.

    Journal of perinatal medicine 2022; (50(7)):985-992 doi:10.1515/jpm-2022-0005.

    PMID: 35405041
  14. 14

    Utility of fetal whole exome sequencing in the etiological evaluation and outcome of nonimmune hydrops fetalis.

    Correa ARE, Naini K, Mishra P, et al.

    Prenatal diagnosis 2021; (41(11)):1414-1424 doi:10.1002/pd.6022.

    PMID: 34302381
  15. 15

    Ten years' experience in prenatal diagnosis of α-thalassemia in a municipal hospital and retrospective analysis of ultrasonic abnormalities.

    Li H, Wang J, Wang D, et al.

    International journal of hematology 2023; (118(3)):355-363 doi:10.1007/s12185-023-03643-6.

    PMID: 37477864
  16. 16

    Invasive prenatal diagnosis of α-thalassemia to control Hb Bart's hydrops fetalis syndrome: 15 years of experience.

    Lai K, Li S, Lin W, et al.

    Archives of gynecology and obstetrics 2018; (298(2)):307-311 doi:10.1007/s00404-018-4807-4.

    PMID: 29948167
  17. 17

    Spontaneous resolution of nonimmune hydrops fetalis in a fetus with TP63 gene mutation and LZTR1 gene variants.

    Hurni Y, Marangoni M, Garofalo G, et al.

    Clinical case reports 2021; (9(8)):e04624 doi:10.1002/ccr3.4624.

    PMID: 34401172

This page provides educational information about the recurrence risk of non-immune hydrops fetalis. Always consult a maternal-fetal medicine specialist or genetic counselor to evaluate your specific medical history and future pregnancy risks.

Get notified when new evidence is published on Non-immune hydrops fetalis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.